Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Firebrick Pharma.
RELATED STOCKHEAD STORIES
News
Rise and Shine: Everything you need to know before the ASX opens
News
CLOSING BELL: The battle to claw back from -0.5% ended in a draw, so we have to come back tomorrow
Health & Biotech
ASX Health Stocks: Firebrick to start Phase 3 trial on common cold spray, MGC Pharma surges 30pc on FDA listing
News
Market Highlights: ASX to bounce back, Goldman says risk-off, and 5 small caps to watch today
Health & Biotech
How out of favour Biotech has a PR problem and could learn from Dr Karl
Health & Biotech
ASX Health Stocks: EMV jumps 7pc after delivering portable brain scanner; Firebrick gets Aussie patent
Health & Biotech
ASX Health Stocks: Singular Health pulling out all the stops to make first US sale
News
Closing Bell: Tech takes control as Asia Pacific markets rise en masse
News
Market Highlights and 5 ASX Small Caps to watch on Wednesday
News
Closing Bell: From Russia with a momentary sense of dread
Experts
ScoPo’s Powerplays: Who’s making a gritty comeback?
News
Closing Bell: Microcaps bounce back while a pharma IPO gains 165% on debut
News